How do NSAIDs cause ulcer disease?

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 14, Issue 1, 2000, Pages 147-159

  Wallace, John L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Acid; Cyclo oxygenase; Neutrophils; Nitric oxide; Non steroidal anti inflammatory drug; Ulcer

Indexed keywords

GROWTH FACTOR; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; SULINDAC;

DIGESTIVE SYSTEM ULCER; DRUG FORMULATION; DUODENUM MUCOSA; HEMOSTASIS; HUMAN; NONHUMAN; PATHOGENESIS; PROSTAGLANDIN SYNTHESIS; REVIEW; STOMACH BLOOD FLOW; STOMACH EPITHELIUM; STOMACH HEMORRHAGE; STOMACH MUCOSA;

EID: 0034061275     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.1999.0065     Document Type: Article

References (96)

1. Douthwaite A H, Lintott S AM. Gastroscopic observation of the effect of aspirin and certain other substances on the stomach. Lancet. 2:1938;1222-1225.
2. Gabriel S E, Bombardier C. NSAID induced ulcers. An emerging epidemic? Journal of Rheumatology. 17:1990;1-4.
3. Singh G, Ramey D R, Morfeld D. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observation cohort study. Archives of Internal Medicine. 156:1996;1530-1536.
4. Bloom B S. Direct medical costs of disease and gastrointestinal side effects during treatment of arthritis. American Journal of Medicine. 83:1988;20-24.
5. Davenport H W. Gastric mucosal hemorrhage in dogs. Effects of acid, aspirin, and alcohol. Gastroenterology. 56:1969;439-449.
6. Fromm D. How do non-steroidal anti-inflammatory drugs affects gastric mucosal defenses? Clinical and Investigative Medicine. 10:1987;251-258.
7. Somasundaram S, Hayllar H, Rafi S. The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis. Scandinavian Journal of Gastroenterology. 30:1995;289-299.
8. Mahmud T, Wrigglesworth J M, Scott D L, Bjarnason I. Mitochondrial function and modification of NSAID carboxyl moiety. Inflammopharmacology. 42:1996;189-194.
9. Estes L L, Fuhs D W, Heaton A H, Butwinick C S. Gastric ulcer perforation, associated with the use of injectable ketorolac. Annals of Pharmacotherapy. 27:1993;42-43.
10. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology. 10:1993;1078-1088.
11. Wallace J L, McKnight G W. Characterization of a simple animal model for nonsteroidal anti-inflammatory drug induced antral ulcer. Canadian Journal of Physiology and Pharmacology. 71:1993;447-452.
12. Lichtenberger L M. The hydrophobic barrier properties of gastrointestinal mucus. Annual Review of Physiology. 57:1995;565-583.
13. Goddard P J, Hills B A, Lichtenberger L M. Does aspirin damage canine gastric mucosa by reducing its hydrophobicity? American Journal of Physiology. 252:1987;G421-G430.
14. Lichtenberger L M, Wang Z M, Romero J J. Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nature Medicine. 1:1995;154-158.
15. Lichtenberger L M, Wang Z M, Giraud M N. Effect of naproxen on gastric mucosal hydrophobicity. Gastroenterology. 108:1995;A149.
16. Graham D Y, Smith J L, Holmes G I, Davies R O. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa. Clinical Pharmacology and Therapeutics. 38:1985;65-70.
17. Carson J L, Strom B L, Soper K A. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Archives of Internal Medicine. 147:1987;1054-1059.
18. Hawthorne A B, Mahida Y R, Cole A T, Hawkey C J. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. British Journal of Clinical Pharmacology. 32:1991;77-83.
19. Lichtenberger L M, Ulloa C, Vanous A L. Zwitterionic phospholipids enhance aspirin's therapeutic activity, as demonstrated in rodent model systems. Journal of Pharmacology and Experimental Therapeutics. 277:1996;1221-1227.
20. Vane J R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature. 231:1971;232-235.
21. 2. Gastroenterology. 70:1976;359-370.
22. Lanza F L. A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other nonsteroidal anti-inflammatory drugs. Scandinavian Journal of Gastroenterology. 24:1989;24-31.
23. Rainsford K D, Willis C. Relationship of gastric mucosal damage induced in pigs by antiinflammatory drugs to their effects on prostaglandin production. Digestive Diseases and Sciences. 27:1982;624-635.
24. Whittle B JR. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology. 80:1981;94-98.
25. Wallace J L, McCafferty D-M, Carter L. Tissue-selective inhibition of prostaglandin synthesis in rat by tepoxalin: anti-inflammatory without gastropathy. Gastroenterology. 105:1993;1630-1636.
26. Wallace J L, Tigley A W. New insights into prostaglandins and mucosal defence. Alimentary Pharmacology and Therapeutics. 9:1995;227-235.
27. Langenbach R, Morham S G, Tiano H F. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 83:1995;483-492.
28. Whittle B JR. Mechanisms underlying gastric mucosal damage induced by indomethacin and bile salts, and the actions of prostaglandins. British Journal of Pharmacology. 60:1977;455-460.
29. Rashid F, Toffolon E P. Misoprostol healed a benign nonsteroidal antiinflammatory drug-induced gastric ulcer in a patient with pentagastrin-fast achlorhydria. Journal of Clinical Gastroenterology. 16:1993;219-221.
30. Janssen M, Dijkmans B AC, Vanderbroucke J P. Achlorhydria does not protect against benign upper gastrointestinal ulcers during NSAID use. Digestive Diseases and Sciences. 39:1994;362-365.
31. Hogaboam C M, Bissonnette E Y, Chin B C. Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology. 104:1993;122-129.
32. Rioux K P, Wallace J L. Mast cell activation increases gastric mucosal injury through peptido-leukotriene release. American Journal of Physiology. 266:1994;G863-G869.
33. Rosam A C, Wallace J L, Whittle B JR. Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature. 319:1986;54-56.
34. Rioux K P, Wallace J L. Mast cells do not contribute to NSAID-induced gastric mucosal injury in rodents. Alimentary Pharmacology and Therapeutics. 10:1996;173-180.
35. Eastwood G L, Quimby G F. Effect of chronic aspirin ingestion on epithelial proliferation in rat fundus, antrum, and duodenum. Gastroenterology. 82:1982;852-856.
36. Wallace J L, Granger D N. The cellular and molecular basis for gastroduodenal mucosal defense. FASEB Journal. 10:1996;731-740.
37. Ashley S W, Sonnenschein L A, Cheung L Y. Focal gastric mucosal blood flow at the site of aspirin-induced ulceration. American Journal of Surgery. 149:1985;53-59.
38. Kitahora T, Guth P H. Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation. Gastroenterology. 93:1987;810-817.
39. Gana T J, Huhlewych R, Koo J. Focal gastric mucosal blood flow in aspirin-induced ulceration. Annals of Surgery. 205:1987;399-403.
40. Rainsford K D. Microvascular injury during gastric damage by anti-inflammatory drugs in pigs and rats. Agents and Actions. 13:1983;457-460.
41. Wallace J L, Keenan C M, Granger D N. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. American Journal of Physiology. 259:1990;G462-G467.
42. Granger D N, Kvietys P R, Perry M A. Leukocyte-endothelial cell adhesion caused by ischemia and reperfusion. Canadian Journal of Physiology and Pharmacology. 71:1993;67-75.
43. Hernandez L A, Grisham M B, Twohig B. Granulocytes: the culprit in ischemic damage to the intestine. American Journal of Physiology. 253:1987;H669-H703.
44. Asako H, Kubes P, Wallace J L. Indomethacin-induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products. American Journal of Physiology. 262:1992;G903-G908.
45. Asako H, Kubes P, Wallace J L. Modulation of leukocyte adhesion to rat mesenteric venules by aspirin and salicylate. Gastroenterology. 103:1992;146-152.
46. Wallace J L, McKnight W, Miyasaka M. Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. American Journal of Physiology. 265:1993;G993-G998.
47. Wallace J L, McKnight G W. The mucoid cap over superficial gastric damage in the rat. A high-pH microenvironment dissipated by nonsteroidal antiinflammatory drugs and endothelin. Gastroenterology. 99:1990;295-304.
48. Yoshida N, Takemura T, Granger D N. Molecular determinants of aspirin-induced neutrophil adherence to endothelial cells. Gastroenterology. 105:1993;715-724.
49. Andrews F J, Malcontenti-Wilson C, O'Brien P E. Effect of nonsteroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa. American Journal of Physiology. 266:1994;G657-G664.
50. Wallace J L, Arfors K-E, McKnight G W. A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit. Gastroenterology. 100:1991;878-883.
51. McCafferty D M, Granger D N, Wallace J L. Indomethacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rats. Gastroenterology. 109:1995;1173-1180.
52. Santucci L, Fiorucci S, Giansanti M. Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. Gut. 35:1994;909-915.
53. Kunkel S L, Wiggins R C, Chensue S W, Larrick J. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochemical and Biophysics Research Communications. 137:1986;404-410.
54. Rothlein R, Czajkowski M, O'Neill M M. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. Journal of Immunology. 141:1988;1665-1669.
55. Appleyard C B, McCafferty D M, Tigley A W. Tumour necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. American Journal of Physiology. 270:1996;G42-G48.
56. Rainsford K D. The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice. Agents and Actions. 21:1987;316-319.
57. Pihan G, Rogers C, Szabo S. Vascular injury in acute gastric mucosal damage: mediatory role of leukotrienes. Digestive Diseases and Sciences. 33:1988;625-632.
58. Vaananen P M, Keenan C M, Grisham M B, Wallace J L. A pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID-gastropathy. Inflammation. 16:1992;227-240.
59. 4synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut. 34:1993;742-747.
60. Taha A S, Dahill S, Morran C. Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers. Gastroenterology. 116:1999;254-258.
61. Taha A S, Hudson N, Hawkey C J. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. New England Journal of Medicine. 334:1996;1435-1439.
62. Del Soldato P, Foschi D, Benoni G, Scarpignato C. Oxygen free radicals interact with indomethacin to cause gastrointestinal injury. Agents and Actions. 17:1985;484-488.
63. Vaananen P M, Meddings J B, Wallace J L. Role of oxygen-derived free radicals in indomethacin-induced gastric injury. American Journal of Physiology. 261:1991;G470-G475.
64. Yoshida N, Cepinskas G, Granger D N. Aspirin-induced, neutrophil-mediated injury to vascular endothelium. Inflammation. 19:1995;297-312.
65. Murakami K, Okajima K, Harada N. Plaunotol prevents indomethacin-induced gastric mucosal injury in rats by inhibiting neutrophil activation. Alimentary Pharmacology and Therapeutics. 13:1999;521-520.
66. Morris G P, Wallace J L. The roles of ethanol and of acid in the production of gastric mucosal erosions in rats. Virchows Archives B (Cell Pathology). 38:1981;23-38.
67. Svanes K, Ito S, Takeuchi K, Silen W. Restitution of the surface epithelium of the in vitro frog gastric mucosa after damage with hyperosmolar sodium chloride. Gastroenterology. 82:1982;1409-1426.
68. Lacy E R, Ito S. Rapid epithelial restitution of the rat gastric mucosa after ethanol injury. Laboratory Investigation. 51:1984;573-583.
69. Moore R, Carlson S, Madara J L. Rapid barrier restitution in an in vitro model of intestinal epithelial injury. Laboratory Investigation. 60:1989;237-244.
70. Wallace J L, Whittle B JR. Role of mucus in repair of gastric epithelial damage in the rat. Inhibition of epithelial recovery by mucolytic agents. Gastroenterology. 91:1986;603-611.
71. Black B A, Morris G P, Wallace J L. Effects of acid on the basal lamina of the rat stomach and duodenum. Virchows Archives B (Cell Pathology). 50:1985;109-118.
72. Armstrong C P, Blower A L. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 28:1997;527-532.
73. Stadler P, Armstrong D, Margalith D. Diclofenac delays healing of gastroduodenal mucosal lesions. Double-blind, placebo-controlled endoscopic study in healthy volunteers. Digestive Diseases and Sciences. 36:1991;594-600.
74. Mizuno H, Sakamoto C, Matsuda K. Induction of cyclooxygenase-2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology. 112:1997;387-397.
75. Schmassmann A, Peskar B M, Stettler C. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. British Journal of Pharmacology. 123:1998;795-804.
76. Jackson L M, Wu K C, Mahida Y R. Cyclooxygenase (COX)-1 and -2 in normal, inflamed and ulcerated human gastric mucosa. Gut. 1999.
77. Reuter B K, Asfaha S, Buret A. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. Journal of Clinical Investigation. 98:1996;2076-2085.
78. Wallace J L. Selective COX-2 inhibitors: is the water becoming muddy? Trends in Pharmacological Sciences. 20:1999;4-6.
79. Wallace J L, McKnight W, Bak A. Selective inhibitors of COX-2: are they really effective? Are they really GI-safe? Journal of Clinical Gastroenterology. 27:1998;S28-S34.
80. Prichard P J, Kitchingman G K, Walt R P. Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. British Medical Journal. 298:1989;493-496.
81. Hawkey C J, Hawthorne A B, Hudson N. Separation of the impairment of haemostasis by aspirin from mucosal injury in the human stomach. Clinical Science. 81:1991;565-573.
82. Lancet. 338:1991;1345-1349.
83. Meade T W, Roderick P J, Brennan P J. Extracranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation. Thrombosis and Haemostasis. 68:1992;1-6.
84. Cryer B, Luk G, Feldman M. Effects of very low doses of aspirin (ASA) on gastric, duodenal & rectal prostaglandins (PGs) & mucosal injury. Gastroenterology. 108:1995;A77.
85. Agrawal N M. Epidemiology and prevention of non-steroidal anti-inflammatory drug effects in the gastrointestinal tract. British Journal of Rheumatology. 34:1995;5-10.
86. Koch M, Capurso L, Dezi A. Prevention of NSAID-induced gastroduodenal mucosal injury: meta-analysis of clinical trials with misoprostol and H2-receptor antagonists. Digestive Diseases. 13:1995;62-74.
87. Simon T J, Berger M L, Hoover M E. A dose-ranging study of famotidine in prevention of gastroduodenal lesions associated with non-steroidal anti-inflammatory drugs (NSAIDs): results of a US multicenter trial. American Journal of Gastroenterology. 89:1994;1644.
88. Hawkey C J, Karrasch J A, Szczepanski L. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. New England Journal of Medicine. 338:1998;727-734.
89. Green F W, Kaplan M M, Curtis L E, Levine P H. Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology. 74:1978;38-43.
90. Szabo S, Folkman J, Vattay P. Accelerated healing of duodenal ulcers by oral administration of a basic fibroblast growth factor in rats. Gastroenterology. 106:1994;1106-1111.
91. Soll A H. Mechanisms of action of antisecretory drugs: studies on isolated canine fundic mucosal cells. Scandinavian Journal of Gastroenterology. 21:1986;1-6.
92. Ligumsky M, Goto Y, Yamada T. Prostaglandins mediate inhibition of gastric acid secretion by somatostatin in the rat. Science. 219:1983;301-303.
93. Xie W, Robertson D L, Simmons D L. Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal antiinflammatory drugs. Drug Development Research. 25:1992;249-265.
94. Wallace J L, Bak A, McKnight W. Cyclooxygenase-1 contributes to inflammatory responses in rats and mice: implications for GI toxicity. Gastroenterology. 115:1998;101-109.
95. Wallace J L, Chapman K, McKnight W. Limited anti-inflammatory efficacy of cyclooxygenase-2 inhibition in carrageenan-airpouch inflammation. British Journal of Pharmacology. 126:1999;1200-1204.
96. Wallace J L, Elliott S N, Del Soldato P. Gastrointestinal sparing anti-inflammatory drugs: the development of nitric oxide-releasing NSAIDs. Drug Development Research. 42:1997;144-149.